Nemes Rush Group’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.9K | Buy |
156
+54
| +53% | +$3.77K | ﹤0.01% | 459 |
|
|
2025
Q1 | $7.5K | Sell |
102
-30
| -23% | -$2.2K | ﹤0.01% | 494 |
|
|
2024
Q4 | $8.62K | Buy |
132
+32
| +32% | +$2.09K | ﹤0.01% | 484 |
|
|
2024
Q3 | $6.78K | Hold |
100
| – | – | ﹤0.01% | 435 |
|
|
2024
Q2 | $7.8K | Sell |
100
-459
| -82% | -$35.8K | ﹤0.01% | 427 |
|
|
2024
Q1 | $37.9K | Sell |
559
-2
| -0.4% | -$136 | 0.01% | 313 |
|
|
2023
Q4 | $37.8K | Buy |
561
+133
| +31% | +$8.96K | 0.01% | 294 |
|
|
2023
Q3 | $29K | Buy |
428
+338
| +376% | +$22.9K | 0.01% | 303 |
|
|
2023
Q2 | $6.44K | Buy |
+90
| New | +$6.44K | ﹤0.01% | 467 |
|